The majority of deaths from malaria are in young African children. Parenteral artesunate (ARS) is the first-line treatment for severe falciparum malaria. Since 2015, the World Health Organization has recommended individual doses of 3 mg/kg for children weighin
SummaryBackgroundSevere malaria is a major cause of childhood death and often the main reason for pa...
Abstract Background Severe malaria results in over a million deaths every year, most of them in chil...
Severe malaria is a major cause of childhood death and often the main reason for paediatric hospital...
Parenteral artesunate (ARS) is the drug of choice for the treatment of severe malaria. Pharmacokinet...
Parenteral artesunate (ARS) is the drug of choice for the treatment of severe malaria. Pharmacokinet...
Background Current artesunate (ARS) regimens for severe malaria are complex. Once daily intramuscula...
<div><p>Background</p><p>Current artesunate (ARS) regimens for severe malaria are complex. Once dail...
largest ever randomized controlled trials in severe falciparum malaria have been reported [1, 2]. Co...
There are ~660,000 deaths from severe malaria each year. Intravenous artesunate (i.v. ARS) is the fi...
Background. We compared a conventional empirically derived regimen with a simplified regimen for par...
A new dose regimen of artesunate and amodiaquine (NDRAA) based on age or body weight range was compa...
A dose regimen of artesunate and amodiaquine based on arm span- or age range (DRAAAS), derived from ...
BACKGROUND: Pharmacokinetic (PK) data on amodiaquine (AQ) and artesunate (AS) are limited in childre...
Most deaths from severe falciparum malaria occur within 24 h of presentation to a hospital. Intraven...
BACKGROUND: Severe malaria is a major cause of childhood death and often the main reason for paediat...
SummaryBackgroundSevere malaria is a major cause of childhood death and often the main reason for pa...
Abstract Background Severe malaria results in over a million deaths every year, most of them in chil...
Severe malaria is a major cause of childhood death and often the main reason for paediatric hospital...
Parenteral artesunate (ARS) is the drug of choice for the treatment of severe malaria. Pharmacokinet...
Parenteral artesunate (ARS) is the drug of choice for the treatment of severe malaria. Pharmacokinet...
Background Current artesunate (ARS) regimens for severe malaria are complex. Once daily intramuscula...
<div><p>Background</p><p>Current artesunate (ARS) regimens for severe malaria are complex. Once dail...
largest ever randomized controlled trials in severe falciparum malaria have been reported [1, 2]. Co...
There are ~660,000 deaths from severe malaria each year. Intravenous artesunate (i.v. ARS) is the fi...
Background. We compared a conventional empirically derived regimen with a simplified regimen for par...
A new dose regimen of artesunate and amodiaquine (NDRAA) based on age or body weight range was compa...
A dose regimen of artesunate and amodiaquine based on arm span- or age range (DRAAAS), derived from ...
BACKGROUND: Pharmacokinetic (PK) data on amodiaquine (AQ) and artesunate (AS) are limited in childre...
Most deaths from severe falciparum malaria occur within 24 h of presentation to a hospital. Intraven...
BACKGROUND: Severe malaria is a major cause of childhood death and often the main reason for paediat...
SummaryBackgroundSevere malaria is a major cause of childhood death and often the main reason for pa...
Abstract Background Severe malaria results in over a million deaths every year, most of them in chil...
Severe malaria is a major cause of childhood death and often the main reason for paediatric hospital...